title: American society of clinical oncology/american society of hematology clinical practice guideline update on the use of epoetin and darbepoetin in adult patients with cancer.
abstract: This guideline update addresses two clinical questions: (1) What are the defining features of patients with a malignancy who are appropriate candidates for ESA treatment? (2) For patients who are appropriate candidates for treatment with ESAs, what are the optimal approaches to ESA therapy?
authors.affiliation: Medical College of Wisconsin, Milwaukee, WI; McMaster University, Hamilton, Ontario, Canada; American Society of Clinical Oncology, Alexandria, VA.
authors.forename: J Douglas
authors.initials: JD
authors.lastname: Rizzo
authors.forename: Melissa
authors.initials: M
authors.lastname: Brouwers
authors.forename: Patricia
authors.initials: P
authors.lastname: Hurley
authors.forename: Jerome
authors.initials: J
authors.lastname: Seidenfeld
authors.forename: Mark R
authors.initials: MR
authors.lastname: Somerfield
authors.forename: Sarah
authors.initials: S
authors.lastname: Temin